Literature DB >> 11000577

Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.

G M Lewandowicz1, B Harding, W Harkness, R Hayward, D G Thomas, J L Darling.   

Abstract

The aim of this study was to examine the range of sensitivity of a panel of short-term cultures derived from different types of malignant childhood brain tumours including medulloblastoma, ependymoma and glioblastoma multiforme to three cytotoxic drugs, lomustine (CCNU), vincristine (VCR) and procarbazine (PCB). Sensitivity was assessed using a modification of the dimethylthiazolyl-2,5-diphenyl tetrazolium bromide (MTT) assay. Short-term cell lines derived from ependymomas were considerably more resistant to VCR than other types of childhood brain tumours, while cultures derived from supratentorial primitive neuroectodermal tumour (PNET) displayed marked sensitivity to both lomustine and VCR. Cultures from ependymomas, medulloblastoma and astrocytic gliomas had similar sensitivity to lomustine and PCB as cultures derived from adult malignant astrocytoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000577     DOI: 10.1016/s0959-8049(00)00245-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.

Authors:  Blanca Suarez-Merino; Mike Hubank; Tamas Revesz; William Harkness; Richard Hayward; Dominic Thompson; John L Darling; David G T Thomas; Tracy J Warr
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

2.  Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.

Authors:  Denis Faoro; André O von Bueren; Tarek Shalaby; Davide Sciuscio; Marie-Louise Hürlimann; Lucia Arnold; Nicolas U Gerber; Johannes Haybaeck; Michel Mittelbronn; Stefan Rutkowski; Monika Hegi; Michael A Grotzer
Journal:  J Neurooncol       Date:  2010-09-05       Impact factor: 4.130

3.  Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridisation and fluorescence in-situ hybridisation.

Authors:  Samantha J Ward; Katherine Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic Thompson; Thomas S Jacques; Brian Harding; John L Darling; David G T Thomas; Tracy J Warr
Journal:  J Neurooncol       Date:  2010-01-06       Impact factor: 4.130

4.  Towards identifying potent new hits for glioblastoma.

Authors:  Chris Sherer; Saurabh Prabhu; David Adams; Joseph Hayes; Farzana Rowther; Ibrahim Tolaymat; Tracy Warr; Timothy J Snape
Journal:  Medchemcomm       Date:  2018-10-02       Impact factor: 3.597

Review 5.  Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models.

Authors:  Ivana Manini; Federica Caponnetto; Anna Bartolini; Tamara Ius; Laura Mariuzzi; Carla Di Loreto; Antonio Paolo Beltrami; Daniela Cesselli
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

6.  A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.

Authors:  Donglai Lv; Shi-Cang Yu; Yi-Fang Ping; Haibo Wu; Xilong Zhao; Huarong Zhang; Youhong Cui; Bing Chen; Xia Zhang; Jianwu Dai; Xiu-Wu Bian; Xiao-Hong Yao
Journal:  Oncotarget       Date:  2016-08-30

7.  Lomustine analogous drug structures for intervention of brain and spinal cord tumors: the benefit of in silico substructure search and analysis.

Authors:  Ronald Bartzatt
Journal:  Chemother Res Pract       Date:  2013-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.